Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description Statistics show that women and underrepresented groups tend to apply to jobs only if they meet 100% of the qualifications. Sobi encourages you to change that statistic and apply. Rarely do candidates meet 100%
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description CRB, das sind über 1.100 visionäre Mitarbeitende, die innovative, nachhaltige Engineering-Lösungen für die Life Science Industrie entwickeln. Wir begleiten unsere Kunden während des gesamten Lebenszyklus ihrer Anlagen – von der strategischen Planung neuer Anlagen,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Salary Range:CHF 0.00 - CHF 0.00 Job Description SummaryWe are excited to invite applications for the Novartis Biomedical Research Postdoctoral Fellowship Program, a unique training opportunity designed for exceptional early-career scientists eager to tackle some of
Salary Range:CHF 0.00 - CHF 0.00 Job Description SummaryThis postdoctoral fellowship offers a unique opportunity to advance the use of artificial intelligence and machine learning for chemical synthesis and reactivity prediction in drug discovery. The successful
Salary Range:CHF 0.00 - CHF 0.00 Job Description SummaryThe Novartis Biomedical Research Postdoctoral Fellowship Program offers a 3-year 100% position starting October 1, 2026, in Basel, Switzerland, focusing on foundational multimodal proteochemometrics models in drug discovery.
Salary Range:CHF 0.00 - CHF 0.00 Job Description SummaryThe AI Innovation Postdoctoral Fellow will develop cutting-edge machine learning and generative AI methods for treatment effect modeling, patient stratification, and virtual clinical trials using large-scale clinical trial
Salary Range:CHF 0.00 - CHF 0.00 Job Description SummaryWe are excited to invite applications for the Novartis Biomedical Research Postdoctoral Fellowship Program, a unique training opportunity designed for exceptional early-career scientists eager to tackle some of
Salary Range:CHF 0.00 - CHF 0.00 Job Description SummaryWe are excited to invite applications for the Novartis Biomedical Research Postdoctoral Fellowship Program, a unique training opportunity designed for exceptional early-career scientists eager to tackle some of
Unternehmensbeschreibung CRB, das sind über 1.100 visionäre Mitarbeitende, die innovative, nachhaltige Engineering-Lösungen für die Life Science Industrie entwickeln. Wir begleiten unsere Kunden während des gesamten Lebenszyklus ihrer Anlagen – von der strategischen Planung neuer Anlagen, der
Company Description CRB, das sind über 1.100 visionäre Mitarbeitende, die innovative, nachhaltige Engineering-Lösungen für die Life Science Industrie entwickeln. Wir begleiten unsere Kunden während des gesamten Lebenszyklus ihrer Anlagen – von der strategischen Planung neuer Anlagen,
Company Description Statistics show that women and underrepresented groups tend to apply to jobs only if they meet 100% of the qualifications. Sobi encourages you to change that statistic and apply. Rarely do candidates meet 100%